Next-Generation Screening - The Promise and Perils of DNA Sequencing of Newborns at Birth: A Workshop

On June 7, the National Academies’ Roundtable on Genomics and Precision Health will host a workshop to examine the use of DNA sequencing as a supplement to traditional newborn screening for treatable but not clinically evident conditions in the newborn phase. The overarching goals of the workshop are to explore the current use of newborn DNA sequencing as well as the known and expected benefits, potential harms, ethical and data security and ownership issues, and equity in access to screening. The workshop may feature family, patient advocate, and public health representative perspectives on the need and capacity for newborn DNA sequencing, as well as potential impacts and risks.

Full event details

When:

Where:

Attend virtually:

• On the day of the event, visit the My Dashboard page to attend virtually.

Attend in person:

• Washington, D.C.

View Agenda